Biotech Webinars
Upcoming Webinars
FierceBiotech offers webinars (also known as webcasts, web seminars and eseminars) on biotech, pharma and other topics to help executives stay informed about pressing industry trends and challenges. Events are led by experts from our editorial staff and often feature presentations from knowledgeable industry insiders. Attendee participation and Q&A is an integral part of each presentation.
On Demand Webinars
It's not too late! Even if you miss the live webcast of a FierceBiotech Webinar, you can stream past webinars from the links on this page.
Webinar: Next Gen Sequencing from FFPE Samples
Next generation sequencing (NGS) technologies hold enormous promise to advance personalized medicine applications in cancer. However, challenging real-world tumor specimens such as FFPE and FNA Read more...
Drug Development: An Overview of the Regulated Clinical Trials Process Used to Bring a New Drug to Market
Join us for a one-hour overview of the regulated clinical trials process used to bring a new drug to market. Topics include: Clinical Trial Considerations, Phase 1, Phase 2a and 2b, Phase 3 and 3b, Read more...
Getting the most out of First-in-Human and Early Clinical Trials
In a follow-up to our webinar last month on first-in-human drug studies, FierceBiotech editor, John Carroll is hosting a second discussion on the increasing complexity of first-in-human/early Read more...
Inside the mHealth Revolution with Welch Allyn: Realizing the Potential of Connected Devices
After launching a line of connected devices, Welch Allyn immediately viewed it as an opportunity to transform their business. In addition to leveraging connectivity to reduce costs and improving Read more...
Active Directory & the Cloud for Biotech & Pharma
Biotech and pharmaceutical companies are leaders cloud/SaaS technology adoption. This webinar will discuss the pros and cons of extending Active Directory to Cloud/SaaS Apps for single sign-on and Read more...
Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine Act
Beginning in 2012, pharmaceutical, biotechnology and medical device companies will be required to monitor, analyze and report on Health Care Professional (HCP) spending as never before. Are your Read more...
Special Studies in Cancer Patients: AME and Cardiac Safety
FierceBiotech Editor John Carroll will moderate an expert panel discussion exploring how cancer drug developers can best evaluate the safety of a new drug at an early stage of development. Gaining a Read more...
Biomarkers and Translational Medicine in Early Phase Oncology Clinical Development (Part two of our three part series)
Increasingly, new technologies are making it possible to carefully identify sets of patients who are most likely to respond to a new drug. And the advances in the field are producing some startling Read more...
